Literature DB >> 15461561

From chemoprevention to chemotherapy: common targets and common goals.

Bharat B Aggarwal1, Yasunari Takada, Oommen V Oommen.   

Abstract

Three decades of research have revealed that cancer is easier to prevent than to treat and that consumption of certain fruits and vegetables can reduce the risk of cancer. Whereas chemotherapy is designed to destroy cancer after it appears, chemoprevention involves the abrogation or delay in the onset of cancer. Regardless of whether a chemopreventive or chemotherapeutic approach is taken, cancer is a multifactorial disease that requires modulation of multiple pathways and multiple targets. Various molecular targets of chemoprevention are also relevant to the therapy of cancer. These targets include the activation of apoptosis; suppression of growth factor expression or signalling; downregulation of antiapoptotic proteins; suppression of phosphatidylinositol-3'-kinase/Akt, NF-kappaB, Janus kinase-signal transducer and activator of transcription and activator protein-1 signalling pathways; and downregulation of angiogenesis through inhibition of vascular endothelial growth factor expression, cyclooxygenase-2, matrix metalloproteinase-9, urokinase-type plasminogen activator, adhesion molecules and cyclin D1. Pharmacologically safe phytochemicals that have been identified from plants or their variant forms can modulate these molecular targets. These phytochemicals include genistein, resveratrol, dially sulfide, S-ally cysteine, allicin, lycopene, capsaicin, curcumin, 6-gingerol, ellagic acid, ursolic acid, betulinic acid, flavopiridol, silymarin, anethol, catechins and eugenol. Recent work has shown that these phytochemicals also can reverse chemoresistance and radioresistance. Because of their pharmacological safety, these agents can be used alone to prevent cancer and in combination with chemotherapy to treat cancer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15461561     DOI: 10.1517/13543784.13.10.1327

Source DB:  PubMed          Journal:  Expert Opin Investig Drugs        ISSN: 1354-3784            Impact factor:   6.206


  48 in total

Review 1.  Targeting tumor ubiquitin-proteasome pathway with polyphenols for chemosensitization.

Authors:  Min Shen; Tak Hang Chan; Q Ping Dou
Journal:  Anticancer Agents Med Chem       Date:  2012-10-01       Impact factor: 2.505

2.  Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st century.

Authors:  Wing-Hin Lee; Ching-Yee Loo; Mary Bebawy; Frederick Luk; Rebecca S Mason; Ramin Rohanizadeh
Journal:  Curr Neuropharmacol       Date:  2013-07       Impact factor: 7.363

Review 3.  Recognition and control of the progression of age-related hearing loss.

Authors:  Hong Miao Ren; Jihao Ren; Wei Liu
Journal:  Rejuvenation Res       Date:  2013-12       Impact factor: 4.663

4.  Novel derivative of benzofuran induces cell death mostly by G2/M cell cycle arrest through p53-dependent pathway but partially by inhibition of NF-kappaB.

Authors:  Sunil K Manna; Julie S Bose; Vijay Gangan; Nune Raviprakash; Thota Navaneetha; Pongali B Raghavendra; Banaganapalli Babajan; Chitta S Kumar; Swatantra K Jain
Journal:  J Biol Chem       Date:  2010-05-14       Impact factor: 5.157

5.  Deguelin, an Akt inhibitor, down-regulates NF-κB signaling and induces apoptosis in colon cancer cells and inhibits tumor growth in mice.

Authors:  Hyoun Woo Kang; Jung Mogg Kim; Mi Yeon Cha; Hyun Chae Jung; In Sung Song; Joo Sung Kim
Journal:  Dig Dis Sci       Date:  2012-05-24       Impact factor: 3.199

6.  Metformin blocks migration and invasion of tumour cells by inhibition of matrix metalloproteinase-9 activation through a calcium and protein kinase Calpha-dependent pathway: phorbol-12-myristate-13-acetate-induced/extracellular signal-regulated kinase/activator protein-1.

Authors:  Yong P Hwang; Hye G Jeong
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

Review 7.  Calix[4]API-s: fully functionalized calix[4]arene-based facial active pharmaceutical ingredients.

Authors:  Fazel Nasuhi Pur
Journal:  Mol Divers       Date:  2020-01-31       Impact factor: 2.943

8.  Isorhamnetin flavonoid synergistically enhances the anticancer activity and apoptosis induction by cis-platin and carboplatin in non-small cell lung carcinoma (NSCLC).

Authors:  Bao-Yi Zhang; Yan-Ming Wang; Hai Gong; Hui Zhao; Xiao-Yan Lv; Guang-Hui Yuan; Shao-Rong Han
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

9.  1,6-Bis[4-(4-amino-3-hydroxyphenoxy)phenyl] diamantane potentiates in vitro and in vivo antitumor effects of irinotecan on human colorectal cancer cells.

Authors:  Po-Sheng Yang; Jane-Jen Wang; Yea-Hwey Wang; Woan-Ching Jan; Shih-Ping Cheng; Yi-Chiung Hsu
Journal:  Oncol Lett       Date:  2016-04-07       Impact factor: 2.967

10.  Characterization of a novel curcumin analog P1 as potent inhibitor of the NF-κB signaling pathway with distinct mechanisms.

Authors:  Yan-min Peng; Jian-bin Zheng; Yu-bo Zhou; Jia Li
Journal:  Acta Pharmacol Sin       Date:  2013-04-22       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.